Remove 2023 Remove Biotech Remove Mergers and acquisition activities
article thumbnail

Pharmaceutical Outsourcing Evolution: The Rise of Clinical Peripheral Services

Frost & Sullivan

Industry Consolidation and Strategic Acquisitions Major CROs are expanding their service portfolios through mergers and acquisitions. These tools enhance patient recruitment, optimize protocol design, and improve real-world data (RWD) utilization.

article thumbnail

JP Morgan Healthcare Conference 2025: Key Growth Opportunities Shaping the Future of Pharma and Biotechnology

Frost & Sullivan

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.